Market Overview

Transcept Pharmaceuticals, Inc. (NASDAQ: )

0.00 0.00 (0.00%)

Earnings

QuarterPriorEstimateActualSurprise
Q4 2013
After-Hours
EPS:
REV:
-0.35
-1.34M
-0.21
500K
-0.29

Q3 2013
Pre-Market
EPS:
REV:
0.25
10.44M
-0.20
210K
-0.25
382K

Q2 2013
Pre-Market
EPS:
REV:


-0.36

Q1 2013
Pre-Market
EPS:
REV:
-0.37
-0.36
-1.52M
-0.56
-5.83M

Q4 2012
Pre-Market
EPS:
REV:
0.37
-0.28
-0.35

Q2 2012
Pre-Market
EPS:
REV:

-0.24
1.87M
-0.30
500K

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!